Five Oceans Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Sell
8,388
-808
-9% -$21.1K 0.06% 201
2026
Q1
$258K Buy
9,196
+208
+2% +$5.54K 0.09% 143
2025
Q4
$224K Sell
8,988
-2
-0% -$50 0.08% 165
2025
Q3
$229K Buy
8,990
+644
+8% +$15.9K 0.08% 161
2025
Q2
$202K Sell
8,346
-537
-6% -$12.5K 0.09% 181
2025
Q1
$225K Buy
+8,883
New +$232K 0.11% 148
2024
Q4
Sell
-10,097
Closed -$292K 195
2024
Q3
$292K Buy
10,097
+2,665
+36% +$77.7K 0.14% 124
2024
Q2
$208K Sell
7,432
-3,772
-34% -$104K 0.11% 160
2024
Q1
$311K Buy
11,204
+676
+6% +$18.8K 0.16% 115
2023
Q4
$303K Sell
10,528
-714
-6% -$21.6K 0.17% 105
2023
Q3
$373K Sell
11,242
-142
-1% -$5.02K 0.24% 85
2023
Q2
$418K Buy
11,384
+1,367
+14% +$53.2K 0.27% 77
2023
Q1
$409K Buy
10,017
+2,483
+33% +$107K 0.26% 84
2022
Q4
$386K Buy
7,534
+169
+2% +$8.1K 0.27% 85
2022
Q3
$322K Sell
7,365
-252
-3% -$12.2K 0.25% 84
2022
Q2
$399K Buy
7,617
+341
+5% +$17.4K 0.3% 69
2022
Q1
$377K Sell
7,276
-169
-2% -$8.77K 0.34% 62
2021
Q4
$440K Buy
7,445
+231
+3% +$11.4K 0.39% 53
2021
Q3
$310K Buy
+7,214
New +$320K 0.36% 65

Other funds holding PFE

Five Oceans Advisors's PFE Position: Q2 2026 in Review

Five Oceans Advisors reduced its Pfizer (PFE) stake by 8.8% in Q2 2026, selling an estimated $21.1K and leaving 8,388 shares worth $202K. The position accounts for 0.06% of the portfolio, ranked #201.

Five Oceans Advisors first reported a position in PFE in Q3 2021 and has held it in 19 quarters since. The position peaked at $440K in Q4 2021. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Five Oceans Advisors held 8,388 shares of Pfizer worth $202K as of Q2 2026.
  • Five Oceans Advisors sold 808 Pfizer shares in Q2 2026, an estimated $21.1K.
  • Pfizer made up 0.06% of Five Oceans Advisors's portfolio in Q2 2026, its #201 holding.
  • Five Oceans Advisors first reported a position in Pfizer in Q3 2021 and has held it in 19 quarters since.
  • Five Oceans Advisors's Pfizer position peaked at $440K in Q4 2021.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.